Company Served as Sponsor and Provided Operational Leadership for Study Conducted in Partnership with TGen and Virta ...

A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic ...

A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...

The trial enrolled patients who received a triplet chemotherapy regimen of nab-paclitaxel, cisplatin, and gemcitabine.

Virta Health, the leader in reversing metabolic disease, announced today results from a randomized, controlled Phase II ...

A new preclinical study in mice shows that precancerous cells in the pancreas can be eliminated before they have the chance to become tumors. Using an experimental therapy to target microscopic ...

WEIGHT loss jabs could slash the risk of death from cancerous tumours by more than a third, experts have suggested. Mounjaro, ...

Virta Health, the leader in reversing metabolic disease, announced today results from a randomized, controlled Phase II clinical trial (RCT), offering an early signal that could reshape how advanced ...

Last month, the United States Food and Drug Administration (FDA) approved a new wearable device for treating pancreatic cancer. This device, called Optune | Cancer ...

Pancreatic cancer survivor Pamela Deasy tells Helen O’Callaghan about the moment she received her shattering diagnosis — how hope was all she had to cling to, how determination got her through. And th ...

People are being urged to watch out for the signs of a 'silent killer' cancer that is said to be one of the hardest to spot. Diagnosis often comes late for the illness because of the hidden signs.